Product Information

OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $2.9811 per ML under NDC 43598076402. Its NADAC has been published 198 times since Feb 1, 2023.

FDA first approved this application on May 20, 2020.

OLOPATADINE HCL 0.2% EYE DROP

Olopatadine Hydrochloride Ophthalmic
$2.9811per ML
OTC

Strength

2 mg/mL

NDC

43598076402

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

OLOPATADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209752

FDA Approved

5/20/2020

On Market Since

9/1/2020

Pharmacological Classes

Decreased Histamine Release
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
Histamine-1 Receptor Inhibitor
Mast Cell Stabilizer

Price Statistics

The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 198 times since Feb 1, 2023, and over the history we have for it it has declined 24.9%. The table below summarizes its recorded NADAC range and movement.

Current price$2.9811 per ML
All-time high$3.9682 (Feb 15, 2023)
All-time low$2.9636 (Sep 23, 2026)
52-week high$3.5799
52-week low$2.9636
Median price$3.3397
Average price$3.3536
Largest weekly change+22.3% (Aug 21, 2024)
Weeks tracked198
Tracking sinceFeb 1, 2023

Price History

1W

0.0%

1M

+0.6%

3M

-0.5%

6M

-3.7%

1Y

-18.6%

3Y

-7.9%

5Y

N/A

All

-24.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by Dr. Reddy's Laboratories Inc., is $2.9811 per ML (NDC 43598076402), effective Nov 11, 2026.

How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?

Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 24.9%. It has been tracked across 198 weekly CMS publications since Feb 1, 2023.

What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?

Since Feb 1, 2023, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $2.9636 (Sep 23, 2026) to a high of $3.9682 (Feb 15, 2023), with a median of $3.3397 per ML.

Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLOPATADINE HCL 0.2% EYE DROP in a comparable dosage form, but none are currently priced below it.

Who manufactures OLOPATADINE HCL 0.2% EYE DROP?

OLOPATADINE HCL 0.2% EYE DROP (NDC 43598076402) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.